Billionaire investor Paulson joins Valeant board, shares jump
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Wall Street ends down as oil prices, Treasury yields rise
Mizuho Securities Maintains Underperform Rating & $8 PT on Valeant Pharma (VRX); 'Rhetoric Changes but Situation Doesn't... Significant Downside Risk to Equity'
June 20, 2017 6:52 AM EDTMizuho Securities maintains Underperform rating and $8 PT on Valeant Pharmaceuticals (NYSE: VRX), following a review of the company's outlook.
Analyst Irina Koffler notes optimistic commentary from management from a recent investor conference regarding capitalization initiatives, while sufficient risks remain with expectations for a second half... More
